Search Results  for '001060.KS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Jw Pharmaceutical: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Jan 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Jw Pharmaceutical (001060-SE)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Jw Pharmaceutical Corp

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Feb 2016 Wright Reports 57 $75.00

JW Pharmaceutical Corporation (001060) - Financial Analysis Review

JW Pharmaceutical Corporation (001060) - Financial Analysis Review Summary JW Pharmaceutical Corporation (JW Pharmaceutical) ...

22 Jan 2016 GlobalData 35 $300.00

JW Pharmaceutical Corporation (001060) - Financial Analysis Review

JW Pharmaceutical Corporation (001060) - Financial Analysis Review Summary JW Pharmaceutical Corporation (JW Pharmaceutical) ...

11 Dec 2015 GlobalData 35 $300.00

JW Pharmaceutical Corporation (001060) - Financial Analysis Review

JW Pharmaceutical Corporation (001060) - Financial Analysis Review Summary JW Pharmaceutical Corporation (JW Pharmaceut...

21 Sep 2015 GlobalData 28 $125.00

Company Snapshot - Choongwae Pharm Corp

A director at Choongwae Pharm Corp sold 1,050 shares at 41,900.000KRW and the significance rating of the trade was 67/100. I...

03 Jul 2015 Directors Deals Ltd. 1 $12.00

JW Pharmaceutical Corporation (001060) - Financial Analysis Review

JW Pharmaceutical Corporation (001060) - Financial Analysis Review Summary JW Pharmaceutical Corporation (JW Pharmaceut...

07 May 2015 GlobalData 28 $125.00

JW Pharmaceutical Corporation (001060) - Financial Analysis Review

JW Pharmaceutical Corporation (001060) - Financial Analysis Review Summary JW Pharmaceutical Corporation (JW Pharmaceut...

06 Jan 2015 GlobalData 28 $125.00

JW Pharmaceutical: Downgraded to Risky

25 Nov 2014 Sadif Analytics Prime 3 $10.00